Charles Schwab
TRIV

Charles Schwab’s TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK TRIV Stock Holding History

Charles Schwab’s Portfolio TRIV Stock Details TRIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-10,900
Closed -$115K – 3180
2015
Q1 		$115K Hold
10,900
– – ﹤0.01% 3020
2014
Q4 		$138K Hold
10,900
– – ﹤0.01% 3032
2014
Q3 		$158K Hold
10,900
– – ﹤0.01% 3004
2014
Q2 		$170K Buy
+10,900
New +$165K ﹤0.01% 3022

Other funds holding TRIV

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
USAA
United Services Automobile Association San Antonio, Texas $851M AUM 5.13% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab's TRIV Position: Q2 2015 in Review

Charles Schwab sold out of TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK (TRIV) in Q2 2015, closing a stake of 10,900 shares — an estimated $115K sold.

Charles Schwab first reported a position in TRIV in Q2 2014 and held it in 4 quarters. The position peaked at $170K in Q2 2014. 36 funds tracked by Wall St. Rank hold TRIV as of Q2 2015.

  • Charles Schwab reported no remaining TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK position as of Q2 2015 after selling out during the quarter.
  • Charles Schwab sold 10,900 TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK shares in Q2 2015, an estimated $115K.
  • Charles Schwab first reported a position in TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK in Q2 2014 and held it in 4 quarters.
  • Charles Schwab's TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK position peaked at $170K in Q2 2014.
  • 36 funds tracked by Wall St. Rank held TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK as of Q2 2015.

Based on Charles Schwab's 13F filing for Q2 2015, filed 14 Aug 2015.